Could Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) score predict poor prognosis in patients with acute ischemic stroke?

Aim: HALP (Hemoglobin, Albumin, Lymphocyte and Platelet) score was shown to have an association with prognosis in malignancies. However, the relationship between HALP score and prognosis in ischemic stroke is not clear. This study aimed to evaluate the relationship between HALP score and functional outcomes at discharge in patients with acute ischemic stroke. Methods: A retrospective analysis was conducted on patients hospitalized with acute ischemic stroke. The HALP score was calculated. The functional status of the patients at discharge were assessed by the Modified Rankin Scale, and patients with mRS≥3 were considered to have a poor prognosis. The relationship between the HALP score, early functional results, and mortality rates of the patients was statistically evaluated. p< 0.05 was considered as significant. Results: After exclusion criteria, data of 159 patients were analyzed. The median HALP score was 41.68. At discharge, 57 patients (35.8%) had poor prognosis. The median HALP score was significantly lower in patients with poor prognosis compared to those with good prognosis (p